Literature DB >> 21144987

Pharmacodynamic approaches to optimizing beta-lactam therapy.

Jared L Crandon1, David P Nicolau.   

Abstract

Given their popularity and favorable safety profile, it is no wonder that there has been considerable interest in developing strategies to most effectively use beta-lactam therapy. Dating back to the first days of penicillin, it was noted that there was an observed benefit to prolonging the infusion time or dosing more frequently. Since that time, considerable research has been performed to help understand and justify these dosing strategies. This article discusses the pharmacology behind these dosing strategies and presents some of the contemporary literature describing the perceived and observed clinical benefits.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21144987     DOI: 10.1016/j.ccc.2010.11.004

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  6 in total

Review 1.  Management of febrile neutropenia in the era of bacterial resistance.

Authors:  Sehnaz Alp; Murat Akova
Journal:  Ther Adv Infect Dis       Date:  2013-02

Review 2.  The prevention and management of infections due to multidrug resistant organisms in haematology patients.

Authors:  Jason A Trubiano; Leon J Worth; Karin A Thursky; Monica A Slavin
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

3.  Oral Fluoroquinolone or Trimethoprim-sulfamethoxazole vs. ß-lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis.

Authors:  Chitra Punjabi; Vivian Tien; Lina Meng; Stan Deresinski; Marisa Holubar
Journal:  Open Forum Infect Dis       Date:  2019-08-14       Impact factor: 3.835

4.  Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae.

Authors:  Xi-Wei Ji; Xiao Zhu; Yun Li; Feng Xue; Isabelle Hui San Kuan; Qing-Feng He; Xiang-Rui Meng; Xiao-Qiang Xiang; Yi-Min Cui; Bo Zheng
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

5.  SYN-007, an Orally Administered Beta-Lactamase Enzyme, Protects the Gut Microbiome from Oral Amoxicillin/Clavulanate without Adversely Affecting Antibiotic Systemic Absorption in Dogs.

Authors:  Sheila Connelly; Brian Fanelli; Nur A Hasan; Rita R Colwell; Michael Kaleko
Journal:  Microorganisms       Date:  2020-01-22

6.  Implementation of an Extended-Infusion Piperacillin-Tazobactam Dosing Protocol: Unexpected Findings when Monitoring Safety and Compliance with Smart Pump Technology.

Authors:  Nathaniel J Rhodes; Jenna Lopez; Cecilia K Pham; Helga Brake; Michael Fotis; Spencer E Harpe; Sean Avedissian; Marc H Scheetz
Journal:  Pharmacy (Basel)       Date:  2019-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.